Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg. 1996;15:250–7. https://doi.org/10.1016/s1085-5629(96)80038-1.

Article  CAS  PubMed  Google Scholar 

Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, et al. The DRESS syndrome: a literature review. Am J Med. 2011;124:588–97. https://doi.org/10.1016/j.amjmed.2011.01.017.

Article  CAS  PubMed  Google Scholar 

Miyagawa F, Asada H. Current perspective regarding the immunopathogenesis of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS). Int J Mol Sci. 2021;22:2417. https://doi.org/10.3390/ijms22042147.

Article  CAS  Google Scholar 

Hama N, Abe R, Gibson A, Phillips EJ. Drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis. J Allergy Clin Immunol Pract. 2022;10:1155-1167.e5. https://doi.org/10.1016/j.jaip.2022.02.004.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ng CY, Yeh YT, Wang CW, Hung SI, Yang CH, Chang YC, et al. Impact of the HLA-B(*)58:01 allele and renal impairment on allopurinol-induced cutaneous adverse reactions. J Invest Dermatol. 2016;136:1373–81. https://doi.org/10.1016/j.jid.2016.02.808.

Article  CAS  PubMed  Google Scholar 

Chung WH, Chang WC, Lee YS, Wu YY, Yang CH, Ho HC, et al. Genetic variants associated with phenytoin-related severe cutaneous adverse reactions. JAMA. 2014;312:525–34. https://doi.org/10.1001/jama.2014.7859.

Article  PubMed  Google Scholar 

Maubec E, Wolkenstein P, Loriot MA, Wechsler J, Mulot C, Beaune P, et al. Minocycline-induced DRESS: evidence for accumulation of the culprit drug. Dermatology. 2008;216:200–4. https://doi.org/10.1159/000112926.

Article  CAS  PubMed  Google Scholar 

Blumenthal KG, Alvarez-Arango S, Fu X, Kroshinsky D, Choi H, Phillips E, et al. Risk factors for vancomycin drug reaction with eosinophilia and systemic symptoms syndrome. JAMA Dermatol. 2022;158:1449–53. https://doi.org/10.1001/jamadermatol.2022.3541.

Article  PubMed  PubMed Central  Google Scholar 

Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169:1071–80. https://doi.org/10.1111/bjd.12501.

Article  CAS  PubMed  Google Scholar 

Sharifzadeh S, Mohammadpour AH, Tavanaee A, Elyasi S. Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review. Eur J Clin Pharmacol. 2021;77:275–89. https://doi.org/10.1007/s00228-020-03005-9.

Article  CAS  PubMed  Google Scholar 

Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy. 2004;59:809–20. https://doi.org/10.1111/j.1398-9995.2004.00547.x.

Article  CAS  PubMed  Google Scholar 

Kumar T, Teo I, McCormick BB. Systemic toxicity of intraperitoneal vancomycin. Case Rep Nephrol. 2016;2016:3968690. https://doi.org/10.1155/2016/3968690.

Article  PubMed  PubMed Central  Google Scholar 

Melis D, Carbone F, Minopoli G, La Rocca C, Perna F, De Rosa V, et al. Cutting edge: increased autoimmunity risk in glycogen storage disease type 1b Is associated with a reduced engagement of glycolysis in T cells and an impaired regulatory T cell function. J Immunol. 2017;198:3803–8. https://doi.org/10.1177/08968608221080586.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kishnani PS, Austin SL, Abdenur JE, Arn P, Bali DS, Boney A, et al. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med. 2014;16: e1. https://doi.org/10.1038/gim.2014.128.

Article  CAS  PubMed  Google Scholar 

Kirchhof MG, Wong A, Dutz JP. Cyclosporine treatment of drug-induced hypersensitivity syndrome. JAMA Dermatol. 2016;152:1254–7. https://doi.org/10.1001/jamadermatol.2016.2220.

Article  PubMed  Google Scholar 

Madigan LM, Fox LP. Vancomycin-associated drug-induced hypersensitivity syndrome. J Am Acad Dermatol. 2019;81:123–8. https://doi.org/10.1016/j.jaad.2019.02.002.

Article  CAS  PubMed  Google Scholar 

Higuchi M, Agatsuma T, Iizima M, Yamazaki Y, Saita T, Ichikawa T, et al. A case of drug-induced hypersensitivity syndrome with multiple organ involvement treated with plasma exchange. Ther Apher Dial. 2005;9:412–6. https://doi.org/10.1111/j.1744-9987.2005.00320.x.

Article  PubMed  Google Scholar 

Oiwa H, Yoshida S, Okada H, Yasunishi M, Kamidani R, Suzuki K, et al. Atypical drug-induced hypersensitivity syndrome with multiple organ failure rescued by combined acute blood purification therapy: a case report. Int J Emerg Med. 2023;16:33. https://doi.org/10.1186/s12245-023-00511-2.

Article  PubMed  PubMed Central  Google Scholar 

Lam E, Lien Y, Kraft W, Kraft W, Piraino B, Vozmediano V, et al. Vancomycin in peritoneal dialysis: clinical pharmacology considerations in therapy. Perit Dial Int. 2020;40:384–93. https://doi.org/10.1177/0896860819889774.

Article  PubMed  Google Scholar 

Böhler J, Reetze-Bonorden P, Keller E, Kramer A, Schollmeyer PJ. Rebound of plasma vancomycin levels after haemodialysis with highly permeable membranes. Eur J Clin Pharmacol. 1992;42:635–9. https://doi.org/10.1007/BF00265928.

Article  PubMed  Google Scholar 

Pollard TA, Lampasona V, Akkerman S, Tom K, Hooks MA, Mullins RE, et al. Vancomycin redistribution: dosing recommendations following high-flux hemodialysis. Kidney Int. 1994;45:232–7. https://doi.org/10.1038/ki.1994.28.

Article  CAS  PubMed  Google Scholar 

Waldman RA, Grant-Kels JM. Thinking outside the box: is there a role for extracorporeal blood purification in DRESS syndrome complicated by acute kidney injury? Clin Dermatol. 2020;38:580–3. https://doi.org/10.1016/j.clindermatol.2020.04.014.

Article  PubMed  Google Scholar 

Rybak MJ. The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis. 2006;42(Suppl 1):S35–9. https://doi.org/10.1086/491712.

Article  CAS  PubMed  Google Scholar 

Li PD, Chow KM, Cho Y, Fan S, Figueiredo AE, Harris T, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022;42:110–53. https://doi.org/10.1177/08968608221080586.

Article  PubMed  Google Scholar